SEC Filing Summary for Sean Godbout's Transaction of Biogen Inc. Common Stock

This filing details transactions made by Sean Godbout, Chief Accounting Officer of Biogen Inc. (BIIB), on April 1, 2026. Godbout acquired 181 shares of Common Stock through the vesting of Restricted Stock Units, with a reported value of $0.00 per share. Following this acquisition, his post-transaction shares totaled 1395.6667. Additionally, Godbout disposed of 54 shares of Common Stock at a price of $183.78 per share, resulting in 1341.6667 shares remaining. The filing also notes the disposal of 181 Restricted Stock Units, which were acquired under a grant on April 1, 2025, and vest in three equal annual installments, with the first installment vesting on April 1, 2026. The disposal of these units resulted in 364 units remaining post-transaction. The transactions were reported on Form 4 and signed by Wendell Taylor as attorney-in-fact for Mr. Godbout on April 3, 2026.